About scopus biopharma inc - SCPS
Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of therapeutics targeting diseases with unmet medical needs. The company was founded on April 18, 2017 and is headquartered in New York, NY.
SCPS At a Glance
Scopus Biopharma, Inc.
420 Lexington Avenue
New York, New York 10170
| Phone | 1-212-479-2513 | Revenue | 0.00 | |
| Industry | Pharmaceuticals: Other | Net Income | -11,609,827.00 | |
| Sector | Health Technology | Employees | 13 | |
| Fiscal Year-end | 12 / 2023 | |||
| View SEC Filings |
SCPS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.122 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
SCPS Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -893,063.615 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
SCPS Liquidity
| Current Ratio | 0.052 |
| Quick Ratio | 0.052 |
| Cash Ratio | 0.017 |
SCPS Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -269.559 |
| Return on Equity | N/A |
| Return on Total Capital | 177.782 |
| Return on Invested Capital | N/A |
SCPS Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |